The MicroCap Rodeo Fall Conference to Host Executive Teams of 19 Companies on October 16th in NYC - AccessWire
TNBI Stock | USD 0.02 0.01 33.33% |
Under 60% of Tanke Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Tanke Biosciences pink sheet suggests that many investors are alarmed at this time. Tanke Biosciences' investing sentiment shows overall attitude of investors towards Tanke Biosciences.
Tanke |
The MicroCap Rodeo Fall Conference to Host Executive Teams of 19 Companies on October 16th in NYC AccessWire
Read at news.google.com
Tanke Biosciences Fundamental Analysis
We analyze Tanke Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Tanke Biosciences is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Tanke Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tanke Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Tanke Biosciences could also be used in its relative valuation, which is a method of valuing Tanke Biosciences by comparing valuation metrics with similar companies.
Peers
Tanke Biosciences Related Equities
AWCA | Awaysis Capital | 30.00 | ||||
ECGR | Bellatora | 6.67 |
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |